Search Results - "Van der Heijden, Antoine G."

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication by Carrasco, Raquel, Izquierdo, Laura, van der Heijden, Antoine G., Lozano, Juan José, Franco, Marco, Ingelmo-Torres, Mercedes, Roldan, Fiorella L., Llorens, Montserrat, Ribal, María José, Mengual, Lourdes, Alcaraz, Antonio

“…This study aimed to ascertain gene expression profile differences between progressive muscle-invasive bladder cancer (MIBC) and de novo MIBC, and to identify…”
Get full text

The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel by Bruins, Harman M., Veskimäe, Erik, Hernández, Virginia, Neuzillet, Yann, Cathomas, Richard, Compérat, Eva M., Cowan, Nigel C., Gakis, Georgios, Espinós, Estefania Linares, Lorch, Anja, Ribal, Maria J., Rouanne, Mathieu, Thalmann, George N., Yuan, Yuhong, der Heijden, Antoine G. van, Witjes, J. Alfred

“…In bladder cancer patients treated with radical cystectomy (RC), controversy exists regarding the impact of the annual hospital volume (HV) and/or surgeon…”
Get full text

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines by Witjes, J. Alfred, Bruins, Harman Max, Cathomas, Richard, Compérat, Eva M., Cowan, Nigel C., Gakis, Georgios, Hernández, Virginia, Linares Espinós, Estefania, Lorch, Anja, Neuzillet, Yann, Rouanne, Mathieu, Thalmann, George N., Veskimäe, Erik, Ribal, Maria J., van der Heijden, Antoine G.

“…This overview presents the updated European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). To provide…”
Get full text

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines by Alfred Witjes, J, Max Bruins, Harman, Carrión, Albert, Cathomas, Richard, Compérat, Eva, Efstathiou, Jason A, Fietkau, Rainer, Gakis, Georgios, Lorch, Anja, Martini, Alberto, Mertens, Laura S, Meijer, Richard P, Milowsky, Matthew I, Neuzillet, Yann, Panebianco, Valeria, Redlef, John, Rink, Michael, Rouanne, Mathieu, Thalmann, George N, Sæbjørnsen, Sæbjørn, Veskimäe, Erik, van der Heijden, Antoine G

“…We present an overview of the updated 2023 European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). To…”
Get full text

The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis by Bruins, Harman Maxim, M.D., Ph.D, Aben, Katja K.H., Ph.D, Arends, Tom J., M.D, van der Heijden, Antoine G., M.D., Ph.D, Witjes, Alfred J., M.D., Ph.D

“…Abstract Introduction Data from single-center series suggest that a delay in time to radical cystectomy (RC) more than 3 months after diagnosis of…”
Get full text

Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer by van Puffelen, Jelmer H., Keating, Samuel T., Oosterwijk, Egbert, van der Heijden, Antoine G., Netea, Mihai G., Joosten, Leo A. B., Vermeulen, Sita H.

“…Intravesical BCG instillation is the gold-standard adjuvant immunotherapy for patients with high-risk non-muscle-invasive bladder cancer. However, the precise…”
Get full text

The Impact of the Extent of Lymphadenectomy on Oncologic Outcomes in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Systematic Review by Bruins, Harman M, Veskimae, Erik, Hernandez, Virginia, Imamura, Mari, Neuberger, Molly M, Dahm, Philip, Stewart, Fiona, Lam, Thomas B, N’Dow, James, van der Heijden, Antoine G, Compérat, Eva, Cowan, Nigel C, De Santis, Maria, Gakis, Georgios, Lebret, Thierry, Ribal, Maria J, Sherif, Amir, Witjes, J. Alfred

“…Abstract Context Controversy exists regarding the therapeutic value of lymphadenectomy (LND) in patients undergoing radical cystectomy (RC) for muscle-invasive…”
Get full text

Longitudinal associations of adherence to lifestyle recommendations and health‐related quality of life in patients with non‐muscle invasive bladder cancer by Vidra, Nikoletta, Beeren, Ivy, Zutphen, Moniek, Aben, Katja K., Kampman, Ellen, Witjes, J. Alfred, Heijden, Antoine G., Kiemeney, Lambertus A., Vrieling, Alina

“…Although the role of lifestyle in health‐related quality of life (HRQoL) outcomes has been increasingly recognized for various types of cancer, evidence in…”
Get full text

The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing Intravesical System (TAR-200) in American Urological Association–defined Intermediate-risk Non–muscle-invasive Bladder Cancer Patients: A Phase 1b Study by P. van Valenberg, F. Johannes, van der Heijden, Antoine G., Cutie, Christopher J., Bhanvadia, Sumeet, Keegan, Kirk A., Hampras, Shalaka, Sweiti, Hussein, Maffeo, John C., Jin, Shu, Chau, Albert, Reynolds, Donald L., Iarossi, Crysti, Kelley, April, Li, Xiang, Stromberg, Katharine A., Michiel Sedelaar, J.P., Steenbruggen, Jessica J.O., Somford, Diederik M., Alfred Witjes, J.

“…In this phase 1b study, TAR-200, a novel drug delivery system, was safe and well tolerated in participants with intermediate-risk non–muscle-invasive bladder…”
Get full text

Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder by van Wilpe, Sandra, Gerretsen, Eveline C F, van der Heijden, Antoine G, de Vries, I Jolanda M, Gerritsen, Winald R, Mehra, Niven

“…The prognosis and responsiveness to chemotherapy and checkpoint inhibitors differs substantially among patients with bladder cancer (BC). There is an unmet…”
Get full text

Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review by Hernández, Virginia, M.D., Ph.D, Espinos, Estefania Linares, M.D., Ph.D, Dunn, James, M.D, MacLennan, Steven, Ph.D, Lam, Thomas, M.D., Ph.D, Yuan, Yuhong, M.D., Ph.D, Compérat, Eva, M.D., Ph.D, Cowan, Nigel C., M.D., Ph.D, Gakis, Georgios, M.D., Ph.D, Lebrét, Thierry, M.D., Ph.D, van der Heijden, Antoine G., M.D., Ph.D, Witjes, Johannes Alfred, M.D., Ph.D, Ribal, Maria J., M.D., Ph.D

“…Abstract Introduction Different sexual function–preserving surgical techniques aimed at improving voiding and sexual function in patients undergoing radical…”
Get full text

Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections by van Puffelen, Jelmer H, Novakovic, Boris, van Emst, Liesbeth, Kooper, Denise, Zuiverloon, Tahlita C M, Oldenhof, Ursula T H, Witjes, J Alfred, Galesloot, Tessel E, Vrieling, Alina, Aben, Katja K H, Kiemeney, Lambertus A L M, Oosterwijk, Egbert, Netea, Mihai G, Boormans, Joost L, van der Heijden, Antoine G, Joosten, Leo A B, Vermeulen, Sita H

“…BackgroundBCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC)…”
Get full text

ICUD-SIU International Consultation on Bladder Cancer 2017: management of non-muscle invasive bladder cancer by Monteiro, Leonardo L., Witjes, J. Alfred, Agarwal, Piyush K., Anderson, Christopher B., Bivalacqua, Trinity J., Bochner, Bernard H., Boormans, Joost L., Chang, Sam S., Domínguez-Escrig, Jose L., McKiernan, James M., Dinney, Colin, Godoy, Guilherme, Kulkarni, Girish S., Mariappan, Paramananthan, O’Donnell, Michael A., Rentsch, Cyrill A., Shah, Jay B., Solsona, Eduardo, Svatek, Robert S., van der Heijden, Antoine G., van Valenberg, F. Johannes P., Kassouf, Wassim

“…Purpose To provide a summary of the Third International Consultation on Bladder Cancer recommendations for the management of non-muscle invasive bladder cancer…”
Get full text

Body mass index and waist circumference in relation to risk of recurrence and progression after non‐muscle invasive bladder cancer by van Zutphen, Moniek, Beeren, Ivy, Aben, Katja K. H., van der Heijden, Antoine G., Witjes, J. Alfred, Kiemeney, Lambertus A. L. M., Vrieling, Alina

“…BackgroundObesity may be associated with increased risk of recurrence and progression in patients with non-muscle invasive bladder cancer (NMIBC), but evidence…”
Get full text

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI by Richters, Anke, Meijer, Richard P, Mehra, Niven, Boormans, Joost L, van der Heijden, Antoine G, van der Heijden, Michiel S, Kiemeney, Lambertus A, Aben, Katja K

“…IntroductionA better understanding of the molecular profile of bladder tumours, the identification of novel therapeutic targets, and introduction of new drugs…”
Get full text

Spatial and Temporal Heterogeneity of Tumor-Infiltrating Lymphocytes in Advanced Urothelial Cancer by van Wilpe, Sandra, Gorris, Mark A J, van der Woude, Lieke L, Sultan, Shabaz, Koornstra, Rutger H T, van der Heijden, Antoine G, Gerritsen, Winald R, Simons, Michiel, de Vries, I Jolanda M, Mehra, Niven

“…Checkpoint inhibitors targeting PD-(L)1 induce objective responses in 20% of patients with metastatic urothelial cancer (UC). CD8 T cell infiltration has been…”
Get full text

Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients by Montalbo, Ruth, Lozano, Juan J., Izquierdo, Laura, Ingelmo-Torres, Mercedes, BaÑos, Carmen, Palou, Joan, Van der Heijden, Antoine G., Medina, Rafael, Schmidbauer, Joerg, Prat, Aleix, Ribal, Maria J., Alcaraz, Antonio, Mengual, Lourdes

“…This study aimed to improve our previous urine gene expression classifiers focusing on the detection of non–high-risk non–muscle-invasive bladder cancer…”
Get full text

Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnostics: The Replacement for Surgery? by van der Heijden, Antoine G., Witjes, J. Alfred

Get full text

Urine cell-based DNA methylation classifier for monitoring bladder cancer by van der Heijden, Antoine G, Mengual, Lourdes, Ingelmo-Torres, Mercedes, Lozano, Juan J, van Rijt-van de Westerlo, Cindy C M, Baixauli, Montserrat, Geavlete, Bogdan, Moldoveanud, Cristian, Ene, Cosmin, Dinney, Colin P, Czerniak, Bogdan, Schalken, Jack A, Kiemeney, Lambertus A L M, Ribal, Maria J, Witjes, J Alfred, Alcaraz, Antonio

“…Current standard methods used to detect and monitor bladder cancer (BC) are invasive or have low sensitivity. This study aimed to develop a urine methylation…”
Get full text

Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort by Richters, Anke, Robbrecht, Debbie G J, Meijer, Richard P, van der Heijden, Antoine G, Kiemeney, Lambertus A L M, van den Bosch, Joan, Suelmann, Britt B M, Özdemir, Berna C, Mehra, Niven, Aben, Katja K H

“…Since 2017, two immune checkpoint inhibitors (ICIs) have become the standard of care for the treatment of metastatic urothelial carcinoma in Europe:…”
Get full text